12/19/2024
4:01 PM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:45 PM | Mersana Therapeutics (Subject)
Nextech Crossover I GP S.a r.l. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:01 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:50 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:27 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:43 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:26 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/15/2024
5:55 AM | Mersana Therapeutics (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
10/07/2024
4:46 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:47 PM | Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:47 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:48 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:48 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:18 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
4:18 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
4:19 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
4:20 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:08 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:06 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:08 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:59 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:18 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
4:31 PM | Hack Andrew A. F. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:49 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:51 PM | Dere Willard H (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:51 PM | Diaz Allene M. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:52 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:53 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:54 PM | Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:26 AM | Mersana Therapeutics (Subject)
Nextech Crossover I GP S.a r.l. (Filed by)
| Form SC 13G | |
05/09/2024
11:15 PM | Mersana Therapeutics (Filer)
| Form EFFECT | |
05/09/2024
4:06 PM | Mersana Therapeutics (Filer)
| Form 424B5 | |
05/09/2024
8:00 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:10 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
5:25 AM | Mersana Therapeutics (Filer)
| Form ARS | |
04/26/2024
5:02 AM | Mersana Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
5:04 AM | Mersana Therapeutics (Filer)
| Form DEFA14A | |
04/03/2024
7:14 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:05 PM | Mersana Therapeutics (Filer)
| Form POS AM | |
02/28/2024
7:49 AM | Mersana Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
7:43 AM | Mersana Therapeutics (Filer)
| Form POSASR | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
02/28/2024
6:07 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Mersana Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
7:43 PM | Mersana Therapeutics (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024
5:55 PM | Mersana Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:20 AM | Avoro Capital Advisors LLC (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:22 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G | |
01/22/2024
12:36 PM | Mersana Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
4:16 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:18 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:18 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:19 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:19 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:20 PM | Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Mersana Therapeutics (Issuer)
MISRA TUSHAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
8:12 PM | Mersana Therapeutics (Subject)
Protopapas Anna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:13 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:13 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:14 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:42 PM | Mersana Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024
7:06 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:14 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free MRSN Stock Alerts